rs141995460
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001145809.2(MYH14):c.4486C>G(p.Gln1496Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00000744 in 1,612,688 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001145809.2 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant nonsyndromic hearing loss 4AInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- peripheral neuropathy-myopathy-hoarseness-hearing loss syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- nonsyndromic genetic hearing lossInheritance: AD Classification: MODERATE Submitted by: ClinGen
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYH14 | NM_001145809.2 | c.4486C>G | p.Gln1496Glu | missense_variant | Exon 33 of 43 | ENST00000642316.2 | NP_001139281.1 | |
| MYH14 | NM_001077186.2 | c.4387C>G | p.Gln1463Glu | missense_variant | Exon 32 of 42 | NP_001070654.1 | ||
| MYH14 | NM_024729.4 | c.4363C>G | p.Gln1455Glu | missense_variant | Exon 31 of 41 | NP_079005.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152250Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000289 AC: 7AN: 242458 AF XY: 0.0000301 show subpopulations
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460320Hom.: 0 Cov.: 32 AF XY: 0.00000826 AC XY: 6AN XY: 726444 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152368Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74514 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The Gln1496Glu variant in MYH14 has not been previously reported in individuals with hearing loss, but it has been identified in 0.52% (1/192) of Luhya (Kenya) chromosomes by the 1000 Genomes Project (dbSNP rs141995460). Although this varia nt has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation anal yses suggest that the Gln1496Glu variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the Gln1496Glu variant is uncertain. -
Inborn genetic diseases Uncertain:1
The c.4363C>G (p.Q1455E) alteration is located in exon 31 (coding exon 30) of the MYH14 gene. This alteration results from a C to G substitution at nucleotide position 4363, causing the glutamine (Q) at amino acid position 1455 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at